Analysts Set MKS Inc. (NASDAQ:MKSI) Target Price at $318.77

Shares of MKS Inc. (NASDAQ:MKSI) have been given a consensus recommendation of “Moderate Buy” by the fifteen analysts that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating, ten have given a buy rating and two have given a strong buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $324.9231.

A number of equities research analysts have recently issued reports on MKSI shares. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $380.00 price objective on shares of MKS in a report on Friday, May 8th. Morgan Stanley boosted their price target on MKS from $354.00 to $374.00 and gave the company an “overweight” rating in a research note on Monday, May 18th. Wells Fargo & Company boosted their price target on MKS from $255.00 to $300.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. TD Cowen reiterated a “buy” rating on shares of MKS in a research note on Thursday, May 7th. Finally, Wall Street Zen cut MKS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 23rd.

Insiders Place Their Bets

In related news, Director Gerald G. Colella sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $333.40, for a total value of $6,668,000.00. Following the completion of the sale, the director directly owned 20,017 shares in the company, valued at approximately $6,673,667.80. The trade was a 49.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Tseng-Chung Lee sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $315.48, for a total value of $3,154,800.00. Following the completion of the sale, the chief executive officer owned 144,696 shares of the company’s stock, valued at approximately $45,648,694.08. This trade represents a 6.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 56,723 shares of company stock valued at $17,830,688 in the last quarter. Company insiders own 0.57% of the company’s stock.

Institutional Investors Weigh In On MKS

Several institutional investors have recently made changes to their positions in the stock. Blue Trust Inc. raised its position in MKS by 1.1% during the first quarter. Blue Trust Inc. now owns 4,274 shares of the scientific and technical instruments company’s stock valued at $982,000 after purchasing an additional 47 shares in the last quarter. Covestor Ltd raised its position in MKS by 14.7% during the fourth quarter. Covestor Ltd now owns 390 shares of the scientific and technical instruments company’s stock valued at $63,000 after purchasing an additional 50 shares in the last quarter. Daiwa Securities Group Inc. raised its position in MKS by 10.4% during the fourth quarter. Daiwa Securities Group Inc. now owns 530 shares of the scientific and technical instruments company’s stock valued at $85,000 after purchasing an additional 50 shares in the last quarter. Quadrant Capital Group LLC raised its position in MKS by 1.3% during the fourth quarter. Quadrant Capital Group LLC now owns 4,335 shares of the scientific and technical instruments company’s stock valued at $693,000 after purchasing an additional 55 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB raised its position in MKS by 6.9% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 898 shares of the scientific and technical instruments company’s stock valued at $144,000 after purchasing an additional 58 shares in the last quarter. 99.79% of the stock is currently owned by institutional investors.

MKS Price Performance

Shares of NASDAQ MKSI opened at $324.26 on Friday. The business’s 50 day moving average price is $276.48 and its two-hundred day moving average price is $224.45. The company has a market cap of $21.90 billion, a PE ratio of 67.84, a price-to-earnings-growth ratio of 1.17 and a beta of 1.98. The company has a quick ratio of 0.70, a current ratio of 1.11 and a debt-to-equity ratio of 0.94. MKS has a twelve month low of $80.22 and a twelve month high of $339.00.

MKS (NASDAQ:MKSI) last announced its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.00 by $0.30. MKS had a return on equity of 21.49% and a net margin of 8.06%.The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the business earned $1.71 earnings per share. The business’s revenue was up 15.2% compared to the same quarter last year. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS. On average, analysts predict that MKS will post 11.73 EPS for the current year.

MKS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Wednesday, June 3rd will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Wednesday, June 3rd. MKS’s payout ratio is 20.92%.

Trending Headlines about MKS

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Zacks Research raised long-term earnings estimates for MKS, including FY2026 EPS of $11.86, FY2027 EPS of $15.00, and FY2028 EPS of $18.24, reinforcing the view that profit growth could remain strong. This kind of higher forward guidance can support the stock by signaling improving earnings power.
• Positive Sentiment: The company’s most recent earnings report beat expectations, with MKS posting $2.30 EPS on $1.08 billion in revenue, both above consensus. Strong results and raised Q2 guidance continue to back the bullish case for MKSI.
• Positive Sentiment: Wall Street has remained broadly constructive, with multiple firms maintaining Buy or Overweight ratings and several raising price targets into the $360-$400 range. That analyst support may be helping keep sentiment positive around MKS.
• Neutral Sentiment: MKS also reaffirmed its quarterly dividend of $0.25 per share, which provides income support but is too small to be a major near-term stock driver.
• Negative Sentiment: Several insiders sold shares recently, including Director Gerald G. Colella, Director Joseph Donahue, and EVP David Philip Henry. While the sales were disclosed as planned transactions in at least some cases, insider selling can still create caution among investors.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.